Market overview
The global augmented glenoid systems market is worth USD 251 mn in 2026 and is forecast to reach USD 567 mn by 2036, growing at a 8.5% CAGR. United States is the largest country market and Wedge augments is the largest by design segment.
| Scope | Shoulder replacement glenoid components with a built-in wedge or step to correct bone loss, used in anatomic and reverse total shoulder surgery. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 230 mn |
| Value 2026 | USD 251 mn |
| Value 2036 | USD 567 mn |
| CAGR 2026-2036 | 8.5% |
| Volume 2026 | 58,277 units |
| Volume 2036 | 119,284 units |
| Average price 2026 | USD 4,302 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Augmented Glenoid Systems market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 251 mn |
| 2027 | USD 272 mn |
| 2028 | USD 295 mn |
| 2029 | USD 320 mn |
| 2030 | USD 347 mn |
| 2031 | USD 377 mn |
| 2032 | USD 409 mn |
| 2033 | USD 444 mn |
| 2034 | USD 481 mn |
| 2035 | USD 522 mn |
| 2036 | USD 567 mn |
Augmented Glenoid Systems market segmentation
By design
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Wedge augments | 52.0% | 50.2% | USD 130 mn | 8.1% |
| Step and half-wedge augments | 30.0% | 29.0% | USD 75 mn | 8.1% |
| Full-wedge and custom augments | 18.0% | 20.9% | USD 45 mn | 10.1% |
By arthroplasty
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Reverse total shoulder | 60.0% | 64.5% | USD 150 mn | 9.3% |
| Anatomic total shoulder | 32.0% | 27.3% | USD 80 mn | 6.8% |
| Revision shoulder | 8.0% | 8.2% | USD 20 mn | 8.8% |
By augment type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Posterior wedge | 42.0% | 40.0% | USD 105 mn | 8.0% |
| Full wedge | 22.0% | 22.0% | USD 55 mn | 8.5% |
| Half wedge | 14.0% | 13.0% | USD 35 mn | 7.7% |
| Step augment | 12.0% | 12.0% | USD 30 mn | 8.5% |
| Patient-specific | 10.0% | 13.0% | USD 25 mn | 11.4% |
By material
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Titanium alloy | 52.0% | 48.0% | USD 130 mn | 7.6% |
| Polyethylene | 24.0% | 23.0% | USD 60 mn | 8.0% |
| Porous metal | 14.0% | 17.0% | USD 35 mn | 10.6% |
| Cobalt chrome | 10.0% | 12.0% | USD 25 mn | 10.5% |
By planning method
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Standard instrumentation | 56.0% | 46.0% | USD 140 mn | 6.4% |
| 3D preoperative planning | 32.0% | 36.0% | USD 80 mn | 9.8% |
| Robotic and navigation | 12.0% | 18.0% | USD 30 mn | 13.0% |
Top 25 countries for augmented glenoid systems by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 94.5% of 2026 revenue and the 25 countries below together hold 98.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 160 mn | 64.0% | USD 358 mn | 8.4% |
| 2 | Germany | USD 13 mn | 5.0% | USD 28 mn | 8.3% |
| 3 | France | USD 13 mn | 5.0% | USD 28 mn | 8.3% |
| 4 | Japan | USD 10 mn | 4.0% | USD 22 mn | 7.9% |
| 5 | United Kingdom | USD 8.8 mn | 3.5% | USD 20 mn | 8.5% |
| 6 | Italy | USD 7.5 mn | 3.0% | USD 17 mn | 8.5% |
| 7 | Australia | USD 7.5 mn | 3.0% | USD 18 mn | 8.9% |
| 8 | Canada | USD 6.3 mn | 2.5% | USD 14 mn | 8.5% |
| 9 | China | USD 6.3 mn | 2.5% | USD 21 mn | 12.8% |
| 10 | Spain | USD 5.0 mn | 2.0% | USD 11 mn | 8.5% |
| 11 | Switzerland | USD 1.9 mn | 0.7% | USD 4.0 mn | 8.1% |
| 12 | Austria | USD 1.5 mn | 0.6% | USD 3.3 mn | 8.1% |
| 13 | Netherlands | USD 1.5 mn | 0.6% | USD 3.3 mn | 8.1% |
| 14 | Belgium | USD 1.4 mn | 0.5% | USD 3.0 mn | 8.1% |
| 15 | South Korea | USD 0.95 mn | 0.4% | USD 2.3 mn | 9.3% |
| 16 | Denmark | USD 0.73 mn | 0.3% | USD 1.6 mn | 8.1% |
| 17 | Sweden | USD 0.70 mn | 0.3% | USD 1.6 mn | 8.5% |
| 18 | Brazil | USD 0.55 mn | 0.2% | USD 1.4 mn | 9.4% |
| 19 | India | USD 0.43 mn | 0.2% | USD 1.0 mn | 9.1% |
| 20 | Israel | USD 0.35 mn | 0.1% | USD 0.74 mn | 7.7% |
| 21 | Taiwan | USD 0.28 mn | 0.1% | USD 0.68 mn | 9.4% |
| 22 | Poland | USD 0.23 mn | 0.09% | USD 0.57 mn | 9.7% |
| 23 | Norway | USD 0.20 mn | 0.08% | USD 0.45 mn | 8.5% |
| 24 | Ireland | USD 0.20 mn | 0.08% | USD 0.40 mn | 7.1% |
| 25 | Mexico | USD 0.18 mn | 0.07% | USD 0.40 mn | 8.5% |
| Rest of world | USD 2.8 mn | 1.1% | USD 5.9 mn | 7.9% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Zimmer Biomet
- Stryker
- Johnson and Johnson MedTech
- Enovis
Group 2: Regional and specialist players
- Arthrex
- Smith and Nephew
- Exactech
- Medacta
- Mathys
- Acumed
- FH Orthopedics
- Lima Corporate
Group 3: Emerging and niche players
- Shoulder Innovations
- Catalyst OrthoScience
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the augmented glenoid systems market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.5% is calculated from the resulting values.
The market is divided by design, by arthroplasty, by augment type, by material, by planning method. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the augmented glenoid systems market?
The global augmented glenoid systems market is estimated at USD 230 mn in 2025 and USD 251 mn in 2026.
How fast will the augmented glenoid systems market grow?
It is forecast to reach USD 567 mn by 2036, a compound annual growth rate of 8.5% from 2026, an increase of USD 316 mn.
Which country is the largest market for augmented glenoid systems?
United States is the largest market by revenue at USD 160 mn in 2026, 64.0% of the global total. The three largest countries together hold 74.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 12.8% a year from 2026 to 2036.
Which augmented glenoid systems segment is largest?
In the by design split, Wedge augments is the largest segment with 52.0% of 2026 revenue.
Who are the leading augmented glenoid systems companies?
Global leaders include Zimmer Biomet, Stryker, Johnson and Johnson MedTech, Enovis.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Automated CPR DeviceUSD 253 mn · 5.5% CAGR
- Dengue VaccinesUSD 247 mn · 22.0% CAGR
- Dental Oral MicrobiomeUSD 255 mn · 10.0% CAGR
- Medical Device Cyber Risk QuantificationUSD 244 mn · 15.0% CAGR
- Continuous Peripheral Nerve Block CatheterUSD 243 mn · 5.0% CAGR
- HIV Self-testingUSD 259 mn · 7.5% CAGR
- Diagnostic Exosome BiomarkersUSD 242 mn · 15.0% CAGR
- Synthetic Clinical Trial DataUSD 260 mn · 22.0% CAGR